Company intelligence / Profile preview

Stealth NewCo

South San Francisco, California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Stealth NewCo is a South San Francisco-based biotech company founded in 2024 that specializes in discovering small molecule drugs for neurodegenerative diseases. The company employs advanced data analytics, biomarkers, high-throughput screening, and structure–activity relationship studies to identify promising therapeutic candidates. Its scientific team has deep experience in drug development. As of now, programs are preclinical with no disclosed clinical results or late-stage assets.

Therapeutic areas: Neurology
Modalities: Small molecules
Industry: Biotech

Beyond the preview

Go deeper on Stealth NewCo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stealth NewCo.

Explore the full profile